Advertisement
Screener

RadNet, Inc. (RDNT) Borrowing debt

RadNet, Inc. (RDNT) Borrowing debt

  • Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
  • Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
  • Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..

Borrowing debt

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total debt · latest quarter (USD)(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Net cash · latest quarter(m)Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Debt / assets · latest quarter(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Borrowing debt due within one year30.67M USDLong-term Debt, Current Maturities
Borrowing debt due after one year1.30B USDLong-term Debt, Excluding Current Maturities
Commercial paper(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value
Borrowing debt(m)Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities
Total assets4.23B USDAssets

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal debtNet cash / debtBorrowing debt due within one year (USD)Borrowing debt due after one year (USD)Commercial paper (USD)Cash and current securities (USD)Total assets (USD)Debt / assets
2026-06-30(m)(m)$30.67M$1.30B(m)(m)$4.23B(m)
2026-03-31(m)(m)$26.51M$1.06B(m)(m)$3.89B(m)
2025-12-31(m)(m)$25.42M$1.06B(m)(m)$3.76B(m)
2025-09-30(m)(m)$25.45M$1.07B(m)(m)$3.67B(m)
2025-06-30(m)(m)$25.48M$1.08B(m)(m)$3.51B(m)
2025-03-31(m)(m)$24.68M$985.45M(m)(m)$3.34B(m)
2024-12-31(m)(m)$24.69M$991.57M(m)(m)$3.29B(m)
2024-09-30(m)(m)$23.38M$996.27M(m)(m)$3.28B(m)
2024-06-30(m)(m)$24.21M$1.00B(m)(m)$3.23B(m)
2024-03-31(m)(m)$20.20M$814.44M(m)(m)$2.97B(m)
2023-12-31(m)(m)$17.97M$812.07M(m)(m)$2.69B(m)
2023-09-30(m)(m)$16.04M$844.30M(m)(m)$2.69B(m)
2023-06-30(m)(m)$15.99M$848.33M(m)(m)$2.71B(m)
2023-03-31(m)(m)$15.94M$852.35M(m)(m)$2.41B(m)
2022-12-31(m)(m)$12.40M$839.34M(m)(m)$2.43B(m)
2022-09-30(m)(m)$10.79M$735.50M(m)(m)$2.25B(m)
2022-06-30(m)(m)$11.16M$737.92M(m)(m)$2.24B(m)
2022-03-31(m)(m)$11.16M$740.71M(m)(m)$2.14B(m)
2021-12-31(m)(m)$11.16M$743.50M(m)(m)$2.06B(m)
2021-09-30(m)(m)$11.16M$746.29M(m)(m)$2.04B(m)
2020-12-31(m)(m)$39.79M$612.91M(m)(m)$1.79B(m)
2012-12-31(m)(m)$-8.64M$573.76M(m)(m)$715.12M(m)
2011-12-31(m)(m)$-12.77M$543.19M(m)(m)$619.19M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70